Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Himax Technologies & Celldex Therapeutics News: (NASDAQ: HIMX), (NASDAQ: CLDX)

HIMX
Himax Technologies & Celldex Therapeutics News: (NASDAQ: HIMX), (NASDAQ: CLDX)

New York (March 3rd, 2013) - Himax Technologies, Inc. (NASDAQ: HIMX) announced the Company will attend the 2013 Bank of America Merrill Lynch Taiwan, Technology & Beyond Conference held at the Far Eastern Plaza Hotel in Taipei from March 12th to March 14th, 2013.

The Company will host 1-1 meetings with conference attendees during the three-day event. Investors looking to schedule a 1-on-1 meeting with the Company should contact their BofA Merrill Lynch representative or Himax investor relations contact.

Himax Technologies, Inc. (HIMX) is a fabless semiconductor solution provider dedicated to display imaging processing technologies. Himax has retained its position as the leading display imaging processing semiconductor solution provider to consumer electronics brands worldwide.

Find out more on HIMX by getting the full trend analysis report here: http://www.wallstreetscoop.net/market-scan/?symbol=HIMX

Celldex Therapeutics, Inc. (NASDAQ: CLDX) will release fourth quarter and year end 2012 financial results on Thursday, March 7, 2013 before the U.S. financial markets open. Celldex executives will host a conference call at 8:30 a.m. ET on the same day to discuss 2012 financial and business results and to provide an update on key 2013 objectives.

Celldex Therapeutics is the first antibody-based combination immunotherapy company. Celldex has a pipeline of drug candidates in development for the treatment of cancer and other difficult-to-treat diseases based on its antibody focused Precision Targeted Immunotherapy (PTI) Platform. The PTI Platform is a complementary portfolio of monoclonal antibodies, antibody-targeted therapeutics and immunomodulators used in optimal combinations to create novel disease-specific drug candidates.

Find out where CLDX could be headed by getting the full and free trend analysis report here: http://www.wallstreetscoop.net/market-scan/?symbol=CLDX


About Us:

WallStreetScoop.net issues momentum alerts on stocks that can provide gains to day traders and short-term investors. WallStreetScoop.net provides members with timely information and exclusive alerts on under-valued stocks in the United States with the potential to deliver short-term gains.

WallStreetScoop.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetScoop.net is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading small cap stocks. Gain an Edge by joining the WallStreetScoop.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Scoop believes traders should have a chance at successfully trading Small stocks and invites traders and investors to be part of the free membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.WallStreetScoop.net

Disclosure: WallStreetScoop.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetScoop.Net website, for complete risks and disclosures.
Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
For full disclaimer visit: www.wallstreetscoop.net/disclaimer/

Contact Info:
Thomas Greene
Wall Street Scoop
info@wallstreetscoop.net
347-905-5009

Tags:


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today